221 related articles for article (PubMed ID: 28735097)
1. Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism.
Ruiz M; Coderre L; Allen BG; Des Rosiers C
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1914-1922. PubMed ID: 28735097
[TBL] [Abstract][Full Text] [Related]
2. The role of NADPH oxidases in diabetic cardiomyopathy.
Hansen SS; Aasum E; Hafstad AD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1908-1913. PubMed ID: 28754449
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
[TBL] [Abstract][Full Text] [Related]
4. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
5. MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction.
Ruiz M; Coderre L; Lachance D; Houde V; Martel C; Thompson Legault J; Gillis MA; Bouchard B; Daneault C; Carpentier AC; Gaestel M; Allen BG; Des Rosiers C
Diabetes; 2016 Feb; 65(2):381-92. PubMed ID: 26558681
[TBL] [Abstract][Full Text] [Related]
6. Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.
Singh RK; Najmi AK
Curr Drug Targets; 2019; 20(4):367-379. PubMed ID: 30112991
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy.
Zuo G; Ren X; Qian X; Ye P; Luo J; Gao X; Zhang J; Chen S
J Cell Physiol; 2019 Feb; 234(2):1925-1936. PubMed ID: 30067872
[TBL] [Abstract][Full Text] [Related]
8. Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca
Liu M; Hoskins A; Verma N; Bers DM; Despa S; Despa F
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1923-1930. PubMed ID: 29066284
[TBL] [Abstract][Full Text] [Related]
9. MG53 and disordered metabolism in striated muscle.
Hu X; Xiao RP
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1984-1990. PubMed ID: 29017896
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.
Nie X; Chanley MA; Pengal R; Thomas DB; Agrawal S; Smoyer WE
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F602-F613. PubMed ID: 29187369
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro.
Singh RK; Diwan M; Dastidar SG; Najmi AK
Hum Exp Toxicol; 2018 May; 37(5):521-531. PubMed ID: 28629242
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance.
Geraets IME; Chanda D; van Tienen FHJ; van den Wijngaard A; Kamps R; Neumann D; Liu Y; Glatz JFC; Luiken JJFP; Nabben M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1960-1967. PubMed ID: 29277329
[TBL] [Abstract][Full Text] [Related]
13. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
[TBL] [Abstract][Full Text] [Related]
14. MK2: a novel molecular target for anti-inflammatory therapy.
Duraisamy S; Bajpai M; Bughani U; Dastidar SG; Ray A; Chopra P
Expert Opin Ther Targets; 2008 Aug; 12(8):921-36. PubMed ID: 18620516
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
Gurgis FM; Ziaziaris W; Munoz L
Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
[TBL] [Abstract][Full Text] [Related]
16. Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases.
Singh RK; Najmi AK; Dastidar SG
Pharmacol Rep; 2017 Aug; 69(4):746-756. PubMed ID: 28582691
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in endothelial dysfunction associated with pulmonary hypertension.
Shafiq M; Lone ZR; Bharati P; Singh H; Jagavelu K; Verma NK; Ghosh JK; Gaestel M; Hanif K
Life Sci; 2021 Dec; 286():120075. PubMed ID: 34678260
[TBL] [Abstract][Full Text] [Related]
18. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
19. Lipid droplet proteins and metabolic diseases.
Xu S; Zhang X; Liu P
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1968-1983. PubMed ID: 28739173
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cardiac energetics by non-invasive
Abdurrachim D; Prompers JJ
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1939-1948. PubMed ID: 29175056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
